Ren-Wang Peng

Prof. Ren-Wang Peng is a cancer researcher specializing in translational oncology and therapeutic resistance. He earned his Ph.D. from the Chinese Academy of Sciences and has conducted research at the Max Planck Institute and ETH Zürich. His work focuses on lung cancer and mesothelioma, with an emphasis on cancer stem cells and drug resistance mechanisms. Prof. Peng has published extensively in leading scientific journals and collaborates internationally on cancer research initiatives. He is currently an Associate Professor and Lab Head at the University Hospital of Bern (Inselspital) and a faculty member at the University of Bern’s Faculty of Medicine.